Validation of prognosis-based in vitro fertilization grant selection criteria
Open Access
- 5 July 2023
- journal article
- research article
- Published by Elsevier in F&S Reports
- Vol. 4 (3) , 286-291
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcomeFertility and Sterility, 2014
- Intra-age, intercenter, and intercycle differences in chromosome abnormalities in oocytesFertility and Sterility, 2012
- Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cyclesHuman Reproduction, 2011
- The uterus and fertilityFertility and Sterility, 2008
- Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registryFertility and Sterility, 2007
- Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal studyFertility and Sterility, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermiaUrology, 1997
- Factors that affect outcome of in-vitro fertilisation treatmentThe Lancet, 1996